450 related articles for article (PubMed ID: 33730348)
1. Trabecular bone score in women with differentiated thyroid cancer on long-term TSH-suppressive therapy.
Sousa BÉCA; Silva BC; de Oliveira Guidotti T; Pires MC; Soares MMS; Kakehasi AM
J Endocrinol Invest; 2021 Oct; 44(10):2295-2305. PubMed ID: 33730348
[TBL] [Abstract][Full Text] [Related]
2. Trabecular bone deterioration in differentiated thyroid cancer: Impact of long-term TSH suppressive therapy.
Hawkins Carranza F; Guadalix Iglesias S; Luisa De Mingo Domínguez M; Martín-Arriscado Arroba C; López Álvarez B; Allo Miguel G; Martínez Díaz-Guerra G
Cancer Med; 2020 Aug; 9(16):5746-5755. PubMed ID: 32583973
[TBL] [Abstract][Full Text] [Related]
3. Low trabecular bone score in postmenopausal women with differentiated thyroid carcinoma after long-term TSH suppressive therapy.
De Mingo Dominguez ML; Guadalix Iglesias S; Martin-Arriscado Arroba C; López Alvarez B; Martínez Diaz-Guerra G; Martinez-Pueyo JI; Ferrero Herrero E; Hawkins Carranza F
Endocrine; 2018 Oct; 62(1):166-173. PubMed ID: 30014437
[TBL] [Abstract][Full Text] [Related]
4. The Effect of TSH Suppression on Vertebral Trabecular Bone Scores in Patients With Differentiated Thyroid Carcinoma.
Moon JH; Kim KM; Oh TJ; Choi SH; Lim S; Park YJ; Park DJ; Jang HC
J Clin Endocrinol Metab; 2017 Jan; 102(1):78-85. PubMed ID: 27754806
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Bone Mineral Density Using DXA and cQCT in Postmenopausal Patients Under Thyrotropin Suppressive Therapy.
Kim K; Kim IJ; Pak K; Kim SJ; Shin S; Kim BH; Kim SS; Lee BJ; Jeon YK
J Clin Endocrinol Metab; 2018 Nov; 103(11):4232-4240. PubMed ID: 29982711
[TBL] [Abstract][Full Text] [Related]
6. Bone mineral density in women receiving thyroxine suppressive therapy for differentiated thyroid carcinoma.
Chen CH; Chen JF; Yang BY; Liu RT; Tung SC; Chien WY; Lu YC; Kuo MC; Hsieh CJ; Wang PW
J Formos Med Assoc; 2004 Jun; 103(6):442-7. PubMed ID: 15278189
[TBL] [Abstract][Full Text] [Related]
7. Application and prospect of trabecular bone score in differentiated thyroid cancer patients receiving thyrotropin suppression therapy.
Ran B; Wei F; Gong J; Xu H
Front Endocrinol (Lausanne); 2022; 13():1004962. PubMed ID: 36313757
[TBL] [Abstract][Full Text] [Related]
8. High-normal free thyroxine levels are associated with low trabecular bone scores in euthyroid postmenopausal women.
Hwangbo Y; Kim JH; Kim SW; Park YJ; Park DJ; Kim SY; Shin CS; Cho NH
Osteoporos Int; 2016 Feb; 27(2):457-62. PubMed ID: 26252978
[TBL] [Abstract][Full Text] [Related]
9. Thyroid-stimulating hormone is associated with trabecular bone score and 5-year incident fracture risk in euthyroid postmenopausal women: the OsteoLaus cohort.
Vendrami C; Marques-Vidal P; Gonzalez Rodriguez E; Hans D; Waeber G; Lamy O
Osteoporos Int; 2022 Jan; 33(1):195-204. PubMed ID: 34409507
[TBL] [Abstract][Full Text] [Related]
10. Effects of TSH suppressive therapy on bone mineral density (BMD) and bone turnover markers (BTMs) in patients with differentiated thyroid cancer in Northeast China: a prospective controlled cohort study.
Wang S; Wang Y; Zhu L; He L; Lv M; Zhang H; Wang H; Zhang F; Lai Y; Li Y; Shan Z; Teng W
Endocrine; 2023 Jan; 79(1):113-124. PubMed ID: 36089636
[TBL] [Abstract][Full Text] [Related]
11. Assessment for bone health in patients with differentiated thyroid carcinoma after postoperative thyroid-stimulating hormone suppression therapy: a new fracture risk assessment algorithm.
Jia H; Qu W; Cai X; Li M; Qian Y; Jiang Z; Zhang Z
Front Endocrinol (Lausanne); 2023; 14():1286947. PubMed ID: 38075039
[TBL] [Abstract][Full Text] [Related]
12. Bone mineral density and bone microarchitecture after long-term suppressive levothyroxine treatment of differentiated thyroid carcinoma in young adult patients.
Mendonça Monteiro de Barros G; Madeira M; Vieira Neto L; de Paula Paranhos Neto F; Carvalho Mendonça LM; Corrêa Barbosa Lima I; Corbo R; Fleiuss Farias ML
J Bone Miner Metab; 2016 Jul; 34(4):417-21. PubMed ID: 26056020
[TBL] [Abstract][Full Text] [Related]
13. The effect of thyroid stimulating hormone suppressive therapy on bone geometry in the hip area of patients with differentiated thyroid carcinoma.
Moon JH; Jung KY; Kim KM; Choi SH; Lim S; Park YJ; Park DJ; Jang HC
Bone; 2016 Feb; 83():104-110. PubMed ID: 26518742
[TBL] [Abstract][Full Text] [Related]
14. Measurements of Bone Health after Thyroid-Stimulating Suppression Therapy in Postmenopausal Women with Differentiated Thyroid Carcinoma: Bone Mineral Density versus the Trabecular Bone Score.
Chung CW; Choi HS; Kong SH; Park YJ; Park DJ; Ahn HY; Cho SW
J Clin Med; 2021 May; 10(9):. PubMed ID: 34063726
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Bone Mineral Density and Trabecular Bone Score in Patients with and without Vertebral Fractures and Differentiated Thyroid Cancer with Long-Term Serum Thyrotrophin-Suppressed Therapy.
Hawkins Carranza F; Arroba CM; López Alvarez MB; Librizzi S; Martínez Díaz Guerra G
Diagnostics (Basel); 2024 Apr; 14(9):. PubMed ID: 38732282
[TBL] [Abstract][Full Text] [Related]
16. Bone loss in premenopausal women on long-term suppressive therapy with thyroid hormone.
Sijanovic S; Karner I
Medscape Womens Health; 2001 Oct; 6(5):3. PubMed ID: 11698925
[TBL] [Abstract][Full Text] [Related]
17. Lack of deleterious effect on bone mineral density of long-term thyroxine suppressive therapy for differentiated thyroid carcinoma.
Reverter JL; Holgado S; Alonso N; Salinas I; Granada ML; Sanmartí A
Endocr Relat Cancer; 2005 Dec; 12(4):973-81. PubMed ID: 16322336
[TBL] [Abstract][Full Text] [Related]
18. Effect of TSH-suppressive doses of levothyroxine on bone mineral density in Thai women.
Ongphiphadhanakul B; Puavilai G; Rajatanavin R
J Med Assoc Thai; 1996 Sep; 79(9):563-7. PubMed ID: 8996984
[TBL] [Abstract][Full Text] [Related]
19. Effects of Thyrotropin Suppression on Bone Health in Menopausal Women with Total Thyroidectomy.
Kim EH; Jeon YK; Pak K; Kim IJ; Kim SJ; Shin S; Kim BH; Kim SS; Lee BJ; Lee JG; Goh TS; Kim K
J Bone Metab; 2019 Feb; 26(1):31-38. PubMed ID: 30899722
[TBL] [Abstract][Full Text] [Related]
20. The atherogenic index of plasma is related to a degraded bone microarchitecture assessed by the trabecular bone score in postmenopausal women: The Camargo Cohort Study.
Hernández JL; Olmos JM; Pariente E; Ramos C; Martínez J; Nan D
Maturitas; 2021 Jun; 148():1-6. PubMed ID: 34024345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]